RecruitingNot ApplicableNCT06573320
Effect of Exercise on Clinical Symptoms, Cognitive Performance, and Quality of Life in Schizophrenia Patients Treated With Clozapine
Investigating the Effect of Exercise on Clinical Symptoms, Cognitive Performance, and Quality of Life in Schizophrenia Patients Treated With Clozapine
Sponsor
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Enrollment
60 participants
Start Date
Mar 14, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This prospective study aims to investigate the effects of exercise on clinical symptoms, cognitive performance, and quality of life in schizophrenia patients treated with Clozapine.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria2
- Patients treated who were diagnosed with schizophrenia according to DSM-V criteria by psychiatrist at the Turkish Ministry of Health Kartal Dr. Lütfi Kırdar City Hospital
- using a therapeutic dose of 300-500 mg/day of clozapine,
Exclusion Criteria1
- pregnancy
Interventions
OTHERphysical exercise
physical exercise
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06573320
Related Trials
Tolerability of MDMA in Schizophrenia
NCT057703751 location
Cerebellar Stimulation and Cognitive Control
NCT032171101 location
A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia
NCT0688278555 locations
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
NCT037940761 location
Cerebellar Modulation of Cognition in Psychosis
NCT061077642 locations